|
Active substance |
Human immunoglobuline |
|
Holder |
CSL Behring nv/sa |
|
Status |
Running |
|
Indication |
Treatment of bleeds in patients with acquired von Willebrand syndrome |
|
Documents publics |
|
|
Last update |
07/10/2022 |
Privigen
Last updated on